Stockscreener 앱 받기
2.60%
시간 외 거래:
전일 마감가:
$231.12
열려 있는:
$233.79
하루 거래량:
871.02K
Relative Volume:
0.49
시가총액:
$28.62B
수익:
$117.76B
순이익/손실:
$1.21B
주가수익비율:
23.83
EPS:
9.95
순현금흐름:
$2.39B
1주 성능:
+4.66%
1개월 성능:
+1.05%
6개월 성능:
-19.29%
1년 성능:
-38.55%
1일 변동 폭
$233.46
$237.29
1주일 범위
$206.87
$237.29
52주 변동 폭
$206.87
$406.09
휴매너 Stock (HUM) Company Profile
명칭
Humana Inc
전화
(502) 580-1000
주소
500 W MAIN ST, LOUISVILLE, KY
HUM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
237.12 | 27.89B | 117.76B | 1.21B | 2.39B | 9.95 |
|
UNH
Unitedhealth Group Inc
|
292.51 | 258.65B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
304.34 | 80.16B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
61.85 | 77.27B | 378.96B | 5.28B | 5.94B | 4.19 |
|
ELV
Elevance Health Inc
|
296.60 | 63.44B | 189.25B | 5.36B | 5.34B | 23.50 |
휴매너 Stock (HUM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-01 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-10-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-10-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-10-02 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | 개시 | Piper Sandler | Overweight |
| 2024-06-24 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-04-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-03-22 | 개시 | Raymond James | Mkt Perform |
| 2024-03-13 | 다운그레이드 | Argus | Buy → Hold |
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2024-01-26 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-12-12 | 업그레이드 | Argus | Hold → Buy |
| 2023-11-08 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-07-07 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-06-23 | 다운그레이드 | Argus | Buy → Hold |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-10-26 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-09-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | 개시 | Loop Capital | Buy |
| 2022-05-27 | 개시 | Bernstein | Mkt Perform |
| 2022-04-13 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | 개시 | Goldman | Neutral |
| 2021-11-04 | 재확인 | Barclays | Overweight |
| 2021-11-04 | 재확인 | Credit Suisse | Outperform |
| 2021-11-04 | 재확인 | Morgan Stanley | Overweight |
| 2021-11-04 | 재확인 | Oppenheimer | Outperform |
| 2021-11-04 | 재확인 | RBC Capital Mkts | Outperform |
| 2021-09-27 | 개시 | SVB Leerink | Outperform |
| 2021-09-10 | 개시 | Cowen | Outperform |
| 2021-09-09 | 재개 | Barclays | Overweight |
| 2021-07-09 | 개시 | Seaport Global Securities | Neutral |
| 2021-05-19 | 개시 | Wells Fargo | Equal Weight |
| 2021-01-04 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | 개시 | Bernstein | Mkt Perform |
| 2020-07-01 | 개시 | SVB Leerink | Outperform |
| 2020-06-16 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-06-05 | 개시 | Goldman | Buy |
| 2020-01-03 | 재확인 | JP Morgan | Overweight |
| 2019-10-18 | 개시 | Mizuho | Buy |
| 2019-09-30 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-08-12 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | 개시 | UBS | Neutral |
| 2019-01-14 | 개시 | Stephens | Overweight |
| 2018-12-20 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-11-08 | 재확인 | BofA/Merrill | Buy |
| 2018-09-13 | 개시 | Barclays | Overweight |
| 2018-07-12 | 재개 | Morgan Stanley | Overweight |
| 2018-07-06 | 재확인 | Piper Jaffray | Overweight |
| 2018-06-01 | 재개 | Citigroup | Buy |
| 2018-02-08 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | 재확인 | Leerink Partners | Outperform |
| 2018-01-12 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
휴매너 주식(HUM)의 최신 뉴스
Humana Accelerates Prior Authorization ReformsRCM Payer - HIT Consultant
Humana is suing CMS over star ratings—again - Healthcare Brew
Humana Commits To Cut One-Third Of Prior Authorization Requirements Following CMS Pledge - Home Health Care News
Humana (HUM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Humana to cut one-third of prior auth requirements by 2026 - Benefits and Pensions Monitor
Fortune 100 health insurer Humana commits to 'greater… - inkl
'We must do better': Fortune 100 firm Humana slashes preapproval mandates in health insurance reform push - Fortune
Poplar Forest Capital LLC Takes Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana (NYSE:HUM) Shares Unloaded Rep. Robert Bresnahan, Jr. - MarketBeat
4,725 Shares in Humana Inc. (NYSE:HUM) Acquired by Convergence Investment Partners LLC - MarketBeat
Oak Thistle LLC Buys New Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana (HUM) to Release Earnings on Wednesday - MarketBeat
Humana to reduce about one-third of prior authorization requirements - Reuters
After dismissal, Humana refiles lawsuit against federal government - The Business Journals
What analysts say about Humana Inc. stockSpectacular growth rates - Autocar Professional
Humana commits to eliminating prior authorization for certain CT, MR imaging exams - Radiology Business
Humana Inc. (NYSE:HUM) Shares Bought by AMG National Trust Bank - MarketBeat
Humana (NYSE:HUM) Hits New 52-Week LowHere's What Happened - MarketBeat
Humana Asks Texas Court To Void 2025 Medicare Ratings - Law360
Humana files second lawsuit challenging Medicare Advantage star ratings - HealthExec
Humana Inc. Stock Analysis and ForecastExplosive earnings growth - jammulinksnews.com
Humana to Reduce About One-Third of Prior Authorization Requirements - HealthLeaders Media
Humana pledges to accelerate reductions in time, number of prior authorizations - Medical Economics
Humana Announces Efforts to Streamline Care Approvals and Reduce Prior Authorization Delays - AInvest
Humana Moves To Cut Prior Authorization Delays, Streamline Care Approvals - Benzinga
Humana to reduce prior authorizations for outpatient services - TechTarget
Humana refiles Medicare Advantage ratings lawsuit against CMS - Modern Healthcare
Humana to drop some outpatient prior authorization requirements - Modern Healthcare
Humana refiles Medicare Advantage star ratings suit - Healthcare Dive
Humana Refiles Challenge to Medicare Quality Rating Cut - Bloomberg Law News
Kennondale Capital Management LLC Cuts Stock Holdings in Humana Inc. (NYSE:HUM) - MarketBeat
Humana To Slash Red Tape Around Prior Authorization For Care Services By 2026: Retail Remains Optimistic - Stocktwits
Humana: CenterWell And Medicaid Key To Offset MA Star Ratings Worries (NYSE:HUM) - Seeking Alpha
Humana's Sharp Decline And Star Rating Troubles Lead Me To Stay Neutral For Now (NYSE:HUM) - Seeking Alpha
What drives Humana Inc. stock priceFree Stock Selection - jammulinksnews.com
Is Humana Inc. a good long term investmentExplosive capital appreciation - jammulinksnews.com
Humana to reduce prior authorization requirements - Reuters
Humana refiles Medicare Star Ratings lawsuit; to slash prior authorization requirements - Seeking Alpha
Humana to reduce prior authorization requirements By Reuters - Investing.com
Humana (HUM) Streamlines Prior Authorization to Boost Efficiency - GuruFocus
Humana to cut prior authorization requirements by one-third - Investing.com Australia
Humana's Strategic Shift in Prior Authorization: A Catalyst for Operational Efficiency and Investor Value - AInvest
Humana Accelerates Efforts to Eliminate Prior Authorization Requ - GuruFocus
Humana to reduce prior authorizations, streamline care approval process By Investing.com - Investing.com Canada
Humana Accelerates Efforts To Eliminate Prior Authorization Requirements To Ensure A Faster, More Seamless Process - TradingView
Humana to publicly report prior authorization metrics in 2026 - AInvest
Where UnitedHealthcare, Humana rule the Medicare Advantage market - Modern Healthcare
Humana to eliminate one-third of prior authorizations by 2026 - StreetInsider
Humana Accelerates Efforts to Eliminate Prior Authorization Requirements to Ensure a Faster, More Seamless Process - Business Wire
Humana Refiles Lawsuit Against Federal Government Over Medicare Advantage Star Ratings Methodology - geneonline.com
Humana refiles Medicare Advantage ratings lawsuit against federal government - statnews.com
휴매너 (HUM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.49%
자본화:
|
볼륨(24시간):